ANGLE presents two posters at EACR
PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCETwo posters highlight the importance of epitope-independent CTC...
Clinical Trial
Radialogica and Scientific RT Announce Release of SciMoCa™ v1.8 with Support for the Elekta Unity MR-Linac and Online Adaptive Applications
ST. LOUIS, Nov. 12, 2024 /PRNewswire/ -- Radialogica LLC and Scientific RT GmbH announced clinical availability of the latest version of...
Xtant Medical Reports Third Quarter 2024 Financial Results
Third Quarter Revenue Growth of 12%Reaffirms Full Year 2024 Revenue Guidance of $116 Million to $120 MillionRepresenting Growth of 27%...
Cosmos Health Issues Letter to Shareholders
CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Artificial Intelligence in Drug Discovery Market to Hit USD 6.89 Billion by 2029 with 29.9% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 12, 2024 /PRNewswire/ -- The global artificial intelligence (AI) in drug discovery market is projected to...
SmoothSkin Introduces Groundbreaking DuoLux Innovations in LED Red Light Therapy
Revolutionizing skincare with cutting-edge LED technology to rejuvenate and enhance skin health. NEW YORK, Nov. 12, 2024 /PRNewswire/ -- SmoothSkin, a...
RealTime eClinical Solutions Expands its Professional Services Offerings to Accelerate eClinical Adoption
SAN ANTONIO, Nov. 12, 2024 /PRNewswire/ -- RealTime eClinical Solutions, a leader in cloud-based software for the clinical research industry,...
New Study from Lindus Health Finds Patients are More Likely to Join a Clinical Trial with Telehealth Care
Survey also finds that participants want to know who has access to their health data, and insist on transparency throughout...
Advarra Publishes 2024 Site-Sponsor-CRO Collaboration Survey Results to Improve Clinical Research
Survey identifies three barriers to stakeholder collaboration, including communications, staffing, and technology, and five key actions to improve alignment. COLUMBIA,...
Formation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug development
PARIS and NEW YORK and SAN FRANCISCO, Nov. 12, 2024 /PRNewswire/ -- Today, Formation Bio, together with OpenAI and Sanofi, introduced...
Compugen Reports Third Quarter 2024 Results
Clinical data presented at SITC 2024 demonstrated COM701 (anti-PVRIG) mediated anti-tumor activity with durable responses and good tolerability profile in tumors...
Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services
EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc., a global CRO, and Medicover Integrated Clinical Services...
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
NDA for CARDAMYST™ in PSVT under review by FDA; PDUFA March 27, 2025MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE...
Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting
-Abstract Highlights New Preclinical Data on Exosome-Based Delivery of PMOs for the Treatment of DMD-SAN DIEGO, Nov. 12, 2024 (GLOBE...
Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108
Commenced enrollment and dosing in Phase 1 clinical study of PALI-2108 for the treatment of moderate-to-severe Ulcerative Colitis (UC) Carlsbad, CA,...
Mustang Bio Receives Positive Listing Determination from Nasdaq
WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
Company accelerated commercialization with significant new partnerships both in the U.S. and EuropeATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Femasys...
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedRxiv and BioRxiv, Respectively
CANOPY manuscript preprint includes six-month off-drug follow-up period that highlighted strong protection by pemivibart versus placebo in the immunocompetent Cohort...
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
Strengthened Cash, Strategic Refocus and Pipeline Progress Define Transformative Quarter€400 million upfront payment from restructured GSK collaboration reflected in financials,...
Yunu Welcomes Veteran Life Sciences Commercial Leader Patrick McNamara
McNamara's extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies brings a wealth of expertise...